POSTER: IBCL-474 Epcoritamab + R2 Regimen and Responses in Patients With High-Risk Follicular Lymphoma, Regardless of POD24 Status
Clinical Lymphoma, Myeloma & Leukemia(2023)
关键词
IBCL,bispecific,follicular lymphoma,hematologic malignancy,non-Hodgkin lymphoma,phase I/II
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要